{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:46:06Z","timestamp":1770835566647,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Autoimmune hepatitis (AIH) is a chronic liver disease caused by inflammation of the liver. The etiology of AIH remains elusive, and there are no reliable serum biomarkers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In order to identify candidate biomarkers, 2-DE analysis of serum proteins was performed using a mouse model of AIH induced by treatment with concanavalin A (ConA). To enrich samples for low abundance molecules a commercial albumin removal reagent was used. In an independent analysis, candidate biomarkers were identified in AIH patient\u2019s serum by a targeted iTRAQ (isobaric tags for relative and absolute quantification) identification. Candidates were validated in independent cohorts of ConA treated mice and AIH patients by ELISA (enzyme-linked immuno sorbent assay).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nine proteins were differentially expressed in AIH mice treated with con-A. Two of these, the third component of complement (C3) and alpha-2-macroglobulin (A2M) were also up-regulated in AIH patient\u2019s sera by a targeted iTRAQ identification. In separate validation studies, serum C3 and A2M levels were increased in mice with ConA treatment after 20-40\u00a0h and in 34 AIH patients in a subgroup analysis, females with AIH aged 20\u201350\u00a0years old displayed the largest increases in serum A2M level. Biological network analysis implements the complement cascade and protease inhibitors in the pathogenesis of AIH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The serum proteins C3 and A2M are increased both in a mouse model and in patients with AIH by both 2-DE and iTRAQ methods. This integrated serum proteomics investigation should be applicable for translational researchers to study other medical conditions.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1479-5876-11-146","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T12:14:20Z","timestamp":1371125660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Complementary serum proteomic analysis of autoimmune hepatitis in mice and patients"],"prefix":"10.1186","volume":"11","author":[{"given":"Hongbin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoshun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongkang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengming","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,13]]},"reference":[{"key":"1551_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL: Autoimmune hepatitis. N Engl J Med. 2006, 354: 54-66. 10.1056\/NEJMra050408.","journal-title":"N Engl J Med"},{"key":"1551_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1478-3231.2009.02092.x","volume":"30","author":"H Chung","year":"2010","unstructured":"Chung H, Watanabe T, Kudo M, Maenishi O, Wakatsuki Y, Chiba T: Identification and characterization of IgG4\u2012associated autoimmune hepatitis. Liver Int. 2010, 30: 222-231. 10.1111\/j.1478-3231.2009.02092.x.","journal-title":"Liver Int"},{"key":"1551_CR3","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1021\/pr700861s","volume":"7","author":"Q Xia","year":"2008","unstructured":"Xia Q, Lu F, Yan HP, Wang HX, Feng X, Zhao Y, Liu BY, Wang J, Li P, Xue Y: Autoantibody profiling of Chinese patients with autoimmune hepatitis using immunoproteomic analysis. J Proteome Res. 2008, 7: 1963-1970. 10.1021\/pr700861s.","journal-title":"J Proteome Res"},{"key":"1551_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jhep.2010.12.012","volume":"55","author":"AW Lohse","year":"2011","unstructured":"Lohse AW, Mieli-Vergani G: Autoimmune hepatitis. J Hepatol. 2011, 55: 171-182. 10.1016\/j.jhep.2010.12.012.","journal-title":"J Hepatol"},{"key":"1551_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11894-011-0236-2","volume":"14","author":"JM Vierling","year":"2012","unstructured":"Vierling JM: Diagnosis and treatment of autoimmune hepatitis. Curr Gastroenterol Rep. 2012, 14: 25-36. 10.1007\/s11894-011-0236-2.","journal-title":"Curr Gastroenterol Rep"},{"key":"1551_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1021\/pr900131e","volume":"9","author":"Q Song","year":"2009","unstructured":"Song Q, Liu G, Hu S, Zhang Y, Tao Y, Han Y, Zeng H, Huang W, Li F, Chen P: Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology. J Proteome Res. 2009, 9: 30-39.","journal-title":"J Proteome Res"},{"key":"1551_CR7","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1373\/49.4.634","volume":"49","author":"E Ballot","year":"2003","unstructured":"Ballot E, Bruneel A, Labas V, Johanet C: Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis. Clin Chem. 2003, 49: 634-643. 10.1373\/49.4.634.","journal-title":"Clin Chem"},{"key":"1551_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/pmic.200300757","volume":"4","author":"S Huguet","year":"2004","unstructured":"Huguet S, Labas V, Duclos\u2012Vallee JC, Bruneel A, Vinh J, Samuel D, Johanet C, Ballot E: Heterogeneous nuclear ribonucleoprotein A2\/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis. Proteomics. 2004, 4: 1341-1345. 10.1002\/pmic.200300757.","journal-title":"Proteomics"},{"key":"1551_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bbrc.2007.12.075","volume":"367","author":"F Lu","year":"2008","unstructured":"Lu F, Xia Q, Ma Y, Yuan G, Yan H, Qian L, Hu M, Wang M, Lu H, Wang H: Serum proteomic-based analysis for the identification of a potential serological marker for autoimmune hepatitis. Biochem Bioph Res Co. 2008, 367: 284-290. 10.1016\/j.bbrc.2007.12.075.","journal-title":"Biochem Bioph Res Co"},{"key":"1551_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/hep.22149","volume":"47","author":"F Tahiri","year":"2008","unstructured":"Tahiri F, Le Naour F, Huguet S, Lai\u2012Kuen R, Samuel D, Johanet C, Saubamea B, Tricottet V, Duclos\u2012Vallee JC, Ballot E: Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology. 2008, 47: 937-948. 10.1002\/hep.22149.","journal-title":"Hepatology"},{"key":"1551_CR11","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1074\/mcp.M112.018713","volume":"11","author":"C Zingaretti","year":"2012","unstructured":"Zingaretti C, Cardaci A, Moro M, Crosti M, Sinisi A, Sugliano E, Cheroni C, Marabita F, Nogarotto R, Bonnal RJP: Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis. Mol Cell Proteomics. 2012, 11: 1885-1897. 10.1074\/mcp.M112.018713.","journal-title":"Mol Cell Proteomics"},{"key":"1551_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0168-8278(00)80425-0","volume":"32","author":"P Obermayer-Straub","year":"2000","unstructured":"Obermayer-Straub P, Strassburg CP, Manns MP: Autoimmune hepatitis. J Hepatol. 2000, 32: 181-197.","journal-title":"J Hepatol"},{"key":"1551_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1379\/CSC-99r.1","volume":"10","author":"DR Ciocca","year":"2005","unstructured":"Ciocca DR, Calderwood SK: Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperon. 2005, 10: 86-103. 10.1379\/CSC-99r.1.","journal-title":"Cell Stress Chaperon"},{"key":"1551_CR14","first-page":"325","volume-title":"Molecular Targets of CNS Tumors","author":"S Liang","year":"2011","unstructured":"Liang S, Shen G: Biomarkers of glioma. Molecular Targets of CNS Tumors. Edited by: Garami M. 2011, InTech Press, 325-342. Available from: http:\/\/www.intechopen.com\/articles\/show\/title\/biomarkers-of-gliomaISBN 978-953-307-736-9"},{"key":"1551_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"Anderson NL, Anderson NG: The human plasma proteome history, character, and diagnostic prospects. Mol Cell Proteomics. 2002, 1: 845-867. 10.1074\/mcp.R200007-MCP200.","journal-title":"Mol Cell Proteomics"},{"key":"1551_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.autrev.2006.04.001","volume":"6","author":"U Christen","year":"2007","unstructured":"Christen U, Holdener M, Hintermann E: Animal models for autoimmune hepatitis. Autoimmun Rev. 2007, 6: 306-311. 10.1016\/j.autrev.2006.04.001.","journal-title":"Autoimmun Rev"},{"key":"1551_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3748\/wjg.v18.i2.119","volume":"18","author":"HX Wang","year":"2012","unstructured":"Wang HX, Liu M, Weng SY, Li JJ, Xie C, He HL, Guan W, Yuan YS, Gao J: Immune mechanisms of concanavalin A model of autoimmune hepatitis. World J Gastroenterol. 2012, 18: 119-125. 10.3748\/wjg.v18.i2.119.","journal-title":"World J Gastroenterol"},{"key":"1551_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4172\/jpb.1000032","volume":"1","author":"F Gong","year":"2008","unstructured":"Gong F, Liang S, He C, Shen G, Xu Y: The optimized conditions of two dimensional polyacrylamide gel electrophoresis for serum proteomics. J Proteomics Bioinform. 2008, 1: 250-257. 10.4172\/jpb.1000032.","journal-title":"J Proteomics Bioinform"},{"key":"1551_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v4010001","volume":"4","author":"AW Tarr","year":"2012","unstructured":"Tarr AW, Urbanowicz RA, Ball JK: The role of humoral innate immunity in hepatitis C virus infection. Viruses. 2012, 4: 1-27. 10.3390\/v4010001.","journal-title":"Viruses"},{"key":"1551_CR20","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/lt.20886","volume":"12","author":"FV Schi\u00f8dt","year":"2006","unstructured":"Schi\u00f8dt FV, Ostapowicz G, Murray N, Satyanarana R, Zaman A, Munoz S, Lee WM: Alpha\u2012fetoprotein and prognosis in acute liver failure. Liver Transplant. 2006, 12: 1776-1781. 10.1002\/lt.20886.","journal-title":"Liver Transplant"},{"key":"1551_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00296-006-0242-0","volume":"27","author":"FC Liu","year":"2007","unstructured":"Liu FC, Chang DM, Lai JH, Lin CK, Chen HC, Hou TY, Kuo SY: Autoimmune hepatitis with raised alpha-fetoprotein level as the presenting symptoms of systemic lupus erythematosus: a case report. Rheumatol Int. 2007, 27: 489-491. 10.1007\/s00296-006-0242-0.","journal-title":"Rheumatol Int"},{"key":"1551_CR22","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.intimp.2011.05.020","volume":"11","author":"JL Aparicio","year":"2011","unstructured":"Aparicio JL, Pe\u00f1a C, Retegui LA: Autoimmune hepatitis-like disease in C57BL\/6 mice infected with mouse hepatitis virus A59. Int Immunopharmacol. 2011, 11: 1591-1598. 10.1016\/j.intimp.2011.05.020.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1551_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000341114","volume":"14","author":"M Hardtke-Wolenski","year":"2012","unstructured":"Hardtke-Wolenski M, Taubert R, Jaeckel E: Animal models of autoimmune liver disease\u2013What is relevant for immune-mediated liver disease?. Dig Dis. 2012, 14 (1): 2-10.","journal-title":"Dig Dis"},{"key":"1551_CR24","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.4049\/jimmunol.154.10.5426","volume":"154","author":"H Molina","year":"1995","unstructured":"Molina H, Perkins SJ, Guthridge J, Gorka J, Kinoshita T, Holers VM: Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules. J Immunol. 1995, 154: 5426-5435.","journal-title":"J Immunol"},{"key":"1551_CR25","first-page":"3","volume":"10","author":"Z Shariat-Madar","year":"2004","unstructured":"Shariat-Madar Z, Schmaier AH: Review: the plasma kallikrein\/kinin and renin angiotensin systems in blood pressure regulation in sepsis. J Endotoxin Res. 2004, 10: 3-13.","journal-title":"J Endotoxin Res"},{"key":"1551_CR26","doi-asserted-by":"publisher","first-page":"14942","DOI":"10.1073\/pnas.0903602106","volume":"106","author":"J Stegbauer","year":"2009","unstructured":"Stegbauer J, Lee DH, Seubert S, Ellrichmann G, Manzel A, Kvakan H, Muller DN, Gaupp S, Rump LC, Gold R: Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci USA. 2009, 106: 14942-14947. 10.1073\/pnas.0903602106.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1551_CR27","first-page":"221","volume":"15","author":"S Liang","year":"2012","unstructured":"Liang S, Xu Z, Xu X, Zhao X, Huang C, Wei Y: Quantitative proteomics for cancer biomarker discovery. Comb Chem High T Scr. 2012, 15: 221-231.","journal-title":"Comb Chem High T Scr"},{"key":"1551_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jcp.28.2.133","volume":"28","author":"A Tunstall","year":"1975","unstructured":"Tunstall A, Merriman J, Milne I, James K: Normal and pathological serum levels of alpha2-macroglobulins in men and mice. J Clin Pathol. 1975, 28: 133-139. 10.1136\/jcp.28.2.133.","journal-title":"J Clin Pathol"},{"key":"1551_CR29","doi-asserted-by":"publisher","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","volume":"34","author":"M Chen","year":"2010","unstructured":"Chen M, Daha MR, Kallenberg CGM: The complement system in systemic autoimmune disease. J Autoimmun. 2010, 34: J276-J286. 10.1016\/j.jaut.2009.11.014.","journal-title":"J Autoimmun"},{"key":"1551_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1744-859X-10-16","volume":"10","author":"MA Flierl","year":"2011","unstructured":"Flierl MA, Gaudiani JL, Sabel AL, Long CS, Stahel PF, Mehler PS: Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease?. Ann Gen Psychiatry. 2011, 10: 10-16. 10.1186\/1744-859X-10-10.","journal-title":"Ann Gen Psychiatry"},{"key":"1551_CR31","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.4314\/tjpr.v7i4.14695","volume":"7","author":"N Hussain","year":"2008","unstructured":"Hussain N, Jaffery G, Hasnain S: Serum complement C3 and C4 levels in relation to diagnosis of lupus nephritis. Trop J Pharm Res. 2008, 7: 1117-1121.","journal-title":"Trop J Pharm Res"},{"key":"1551_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jcp.33.2.163","volume":"33","author":"K James","year":"1980","unstructured":"James K, Merriman J, Gray R, Duncan L, Herd R: Serum alpha 2-macroglobulin levels in diabetes. J Clin Pathol. 1980, 33: 163-166. 10.1136\/jcp.33.2.163.","journal-title":"J Clin Pathol"},{"key":"1551_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.clim.2011.02.004","volume":"104","author":"X Gao","year":"2011","unstructured":"Gao X, Liu H, Ding G, Wang Z, Fu H, Ni Z, Ma J, Liu F, Fu Z: Complement C3 deficiency prevent against the onset of streptozotocin-induced autoimmune diabetes involving expansion of regulatory T cells. Clin Immunol. 2011, 104: 236-243.","journal-title":"Clin Immunol"},{"key":"1551_CR34","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.4049\/jimmunol.1002948","volume":"186","author":"AJ Laarman","year":"2011","unstructured":"Laarman AJ, Ruyken M, Malone CL, Van Strijp JAG, Horswill AR, Rooijakkers SHM: Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J Immunol. 2011, 186: 6445-6453. 10.4049\/jimmunol.1002948.","journal-title":"J Immunol"},{"key":"1551_CR35","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.imbio.2010.08.004","volume":"216","author":"Z Tu","year":"2011","unstructured":"Tu Z, Li Q, Chou HS, Hsieh CC, Meyerson H, Peters MG, Bu H, Fung JJ, Qian S, Lu L: Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology. 2011, 216: 528-534. 10.1016\/j.imbio.2010.08.004.","journal-title":"Immunobiology"},{"key":"1551_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1479-5876-5-33","volume":"5","author":"IR White","year":"2007","unstructured":"White IR, Patel K, Symonds WT, Dev A, Griffin P, Tsokanas N, Skehel M, Liu C, Zekry A, Cutler P: Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. J Transl Med. 2007, 5: 33-41. 10.1186\/1479-5876-5-33.","journal-title":"J Transl Med"},{"key":"1551_CR37","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1002\/pmic.200800497","volume":"8","author":"NS Vasudev","year":"2008","unstructured":"Vasudev NS, Ferguson RE, Cairns DA, Stanley AJ, Selby PJ, Banks RE: Serum biomarker discovery in renal cancer using 2\u2012DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?. Proteomics. 2008, 8: 5074-5085. 10.1002\/pmic.200800497.","journal-title":"Proteomics"},{"key":"1551_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/omi.2008.0075","volume":"13","author":"J Zhou","year":"2009","unstructured":"Zhou J, Liang S, Fang L, Chen L, Tang M, Xu Y, Fu A, Yang J, Wei Y: Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009, 13: 93-103. 10.1089\/omi.2008.0075.","journal-title":"OMICS"},{"key":"1551_CR39","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1002\/elps.200900249","volume":"30","author":"S Liang","year":"2009","unstructured":"Liang S, Xu Y, Shen G, Liu Q, Zhao X, Xu Z, Xie X, Gong F, Li R, Wei Y: Quantitative protein expression profiling of 14\u20123\u20123 isoforms in human renal carcinoma shows 14\u20123\u20123 epsilon is involved in limitedly increasing renal cell proliferation. Electrophoresis. 2009, 30: 4152-4162. 10.1002\/elps.200900249.","journal-title":"Electrophoresis"},{"key":"1551_CR40","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/nprot.2010.123","volume":"5","author":"RD Unwin","year":"2010","unstructured":"Unwin RD, Griffiths JR, Whetton AD: Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS\/MS. Nat Protoc. 2010, 5: 1574-1582. 10.1038\/nprot.2010.123.","journal-title":"Nat Protoc"},{"key":"1551_CR41","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1021\/pr100192h","volume":"9","author":"PK Chong","year":"2010","unstructured":"Chong PK, Lee H, Zhou J, Liu SC, Loh MCS, Wang TT, Chan SP, Smoot DT, Ashktorab H, So JBY: ITIH3 is a potential biomarker for early detection of gastric cancer. J Proteome Res. 2010, 9: 3671-3679. 10.1021\/pr100192h.","journal-title":"J Proteome Res"},{"key":"1551_CR42","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1002\/pmic.200700455","volume":"7","author":"Y Ogata","year":"2007","unstructured":"Ogata Y, Charlesworth MC, Higgins LA, Keegan BM, Vernino S, Muddiman DC: Differential protein expression in male and female human lumbar cerebrospinal fluid using iTRAQ reagents after abundant protein depletion. Proteomics. 2007, 7: 3726-3734. 10.1002\/pmic.200700455.","journal-title":"Proteomics"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-11-146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T10:42:03Z","timestamp":1688294523000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-11-146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,13]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1551"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-11-146","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,13]]},"assertion":[{"value":"1 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"146"}}